Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

被引：0
|
作者：
Eleanor O’Brien
Carmen Tse
Ian Tracy
Ian Reddin
Joanna Selfe
Jane Gibson
William Tapper
Reuben J. Pengelly
Jinhui Gao
Ewa Aladowicz
Gemma Petts
Khin Thway
Sergey Popov
Anna Kelsey
Timothy J. Underwood
Janet Shipley
Zoë S. Walters
机构：
[1] The Institute of Cancer Research,Divisions of Molecular Pathology and Cancer Therapeutics
[2] University of Southampton,Cancer Sciences, Faculty of Medicine
[3] University of Southampton,Human Development and Health, Faculty of Medicine
[4] Royal Marsden NHS Foundation Trust,Pathology Department
[5] Cardiff and Vale UHB,Cellular Pathology Department
[6] University of Manchester Foundation Trust,Department of Paediatric Pathology
来源：
Clinical Epigenetics | / 15卷
关键词：
Rhabdomyosarcoma; Differentiation therapy; Epigenetic therapy; EZH2; All-trans retinoic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
    O'Brien, Eleanor
    Tse, Carmen
    Tracy, Ian
    Reddin, Ian
    Selfe, Joanna
    Gibson, Jane
    Tapper, William
    Pengelly, Reuben J.
    Gao, Jinhui
    Aladowicz, Ewa
    Petts, Gemma
    Thway, Khin
    Popov, Sergey
    Kelsey, Anna
    Underwood, Timothy J.
    Shipley, Janet
    Walters, Zoe S.
    CLINICAL EPIGENETICS, 2023, 15 (01)
  • [2] EZH2 deletion promotes spermatogonial differentiation and apoptosis
    Jin, Cheng
    Zhang, Yan
    Wang, Zhi-Peng
    Wang, Xiu-Xia
    Sun, Tie-Cheng
    Li, Xiao-Yu
    Tang, Xin
    Cheng, Jin-Mei
    Li, Jian
    Chen, Su-Ren
    Deng, Shou-Long
    Liu, Yi-Xun
    REPRODUCTION, 2017, 154 (05) : 615 - 625
  • [3] Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
    Ciarapica, Roberta
    Carcarino, Elena
    Adesso, Laura
    De Salvo, Maria
    Bracaglia, Giorgia
    Leoncini, Pier Paolo
    Dall'Agnese, Alessandra
    Verginelli, Federica
    Milano, Giuseppe M.
    Boldrini, Renata
    Inserra, Alessandro
    Stifani, Stefano
    Screpanti, Isabella
    Marquez, Victor E.
    Valente, Sergio
    Mai, Antonello
    Puri, Pier Lorenzo
    Locatelli, Franco
    Palacios, Daniela
    Rota, Rossella
    BMC CANCER, 2014, 14
  • [4] Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
    Roberta Ciarapica
    Elena Carcarino
    Laura Adesso
    Maria De Salvo
    Giorgia Bracaglia
    Pier Paolo Leoncini
    Alessandra Dall’Agnese
    Federica Verginelli
    Giuseppe M Milano
    Renata Boldrini
    Alessandro Inserra
    Stefano Stifani
    Isabella Screpanti
    Victor E Marquez
    Sergio Valente
    Antonello Mai
    Pier Lorenzo Puri
    Franco Locatelli
    Daniela Palacios
    Rossella Rota
    BMC Cancer, 14
  • [5] EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma
    Mushtaq, Muhammad
    Liano-Pons, Judit
    Wang, Jiansheng
    Alzrigat, Mohammad
    Yuan, Ye
    Ruiz-Perez, Maria Victoria
    Chen, Yi
    Kashuba, Elena
    de Flon, Felix Haglund
    Brodin, Bertha
    Arsenian-Henriksson, Marie
    CELL DEATH & DISEASE, 2024, 15 (11):
  • [6] Combined inhibition of histone deacetylases and EZH2 for the treatment of Wilms tumors
    Liu, Hongbing
    Ngo, Nhi
    Chen, Chao-Hui
    El-Dahr, Samir S.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [7] FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation
    Sung, Pamela J.
    Sidoli, Simone
    Riedel, Simone S.
    Kulej, Katarzyna
    Xie, Hongbo
    Manning, Bryan
    Tsai, Daniel
    Wertheim, Gerald
    Garcia, Benjamin A.
    Meyer, Sara E.
    Bernt, Kathrin M.
    Carroll, Martin P.
    BLOOD, 2021, 138
  • [8] Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2
    Qin, Wei
    Yang, Lin
    Chen, Xiaotong
    Ye, Shanyu
    Liu, Aijun
    Chen, Dongfeng
    Hu, Kunhua
    INTERNATIONAL JOURNAL OF STEM CELLS, 2023, 16 (03) : 326 - 341
  • [9] The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines
    Schmidt, Andreas
    Behrendt, Lucas
    Eybe, Jana
    Warmann, Steven W.
    Schleicher, Sabine
    Fuchs, Joerg
    Schmid, Evi
    CANCERS, 2022, 14 (01)
  • [10] Pharmacological inhibition of EZH2 disrupts the female germline epigenome
    Prokopuk, Lexie
    Hogg, Kirsten
    Western, Patrick S.
    CLINICAL EPIGENETICS, 2018, 10
12345